Icon

KEVEYIS (nda011366)- (50MG)

DICHLORPHENAMIDE XERIS
50MG
No No
Expired Expired
2022-Aug-07 None
None No
KEVEYIS is an oral carbonic anhydrase inhibitor indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants.
1 0 1
Total Other Developers 3
Drugs with Suitability No
50MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 1
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ******* ****** ****** ******* ******* *********** **** **. **/*, **, ** ** **, ***** ***, *** ***********, *********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.